[5-(3-Trifluoromethoxy-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 1g

2,2,2-Trifluoro-1-(pyridin-3-yl)ethanone hydrochloride, 95.0%, 5g

2,4,6-Trichlorophenylboronic acid, 98.0%, 5g

Methyl 2-(bromomethyl)-3-furoate, 95.0%, 5g

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-, 97%, 250mg

3-METHOXY-N-(1-METHYLPIPERIDIN-4-YL)-4-((4-((3-OXO-2,3-DIHYDRO-1H-INDEN-4-YL)OXY)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL)AMINO)BENZAMIDE, 95%, 1g

Trichloromethane/chloroform, min. 99%, DAB, BP, extra pure, 2.5 l, glass packaging

Methyl 3-formyl-1H-indole-6-carboxylate, 95.0%, 1g

2-chloro-1-(pyrazin-2-yl)ethan-1-one, 95.0%, 250mg

(1R)-6-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95.0%, 250mg

6-(Methylthio)-9H-purine, 97.0%, 1g

1-Boc-(4-N-Boc-amino)piperidine-4-carboxylic acid, 97.0%, 25g

(S)-a-(4-Biphenylmethyl)proline�HCl, 250mg